Skip to main content

Find Clinical Trials

Home
Conditions
Parkinson Disease

Clinical trial condition

Parkinson Disease

Explore clinical trials studying Parkinson Disease. Study availability and eligibility vary by location and protocol.

1,814 public trials 369 recruiting studies

Refine in advanced search Browse all conditions

Parkinson Disease trial results

Completed

Study Evaluating Sumanirole for the Treatment of the Signs and Symptoms of Early Parkinson's Disease

NCT00058838

Conditions: Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +6 more
Locations: Pfizer Investigational Site Birmingham, Alabama, United States

Pfizer Investigational Site Birmingham, Alabama, United States

Pfizer Investigational Site Huntsville, Alabama, United States

Pfizer Investigational Site Little Rock, Arkansas, United States

View all 134 locations

View Trial Details

Completed

Study Evaluating Sumanirole for the Treatment of the Signs and Symptoms of Early Parkinson's Disease.

NCT00036218

Conditions: Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +6 more
Locations: Pfizer Investigational Site Hot Springs, Arkansas, United States

Pfizer Investigational Site Little Rock, Arkansas, United States

Pfizer Investigational Site Carmichael, California, United States

Pfizer Investigational Site Fresno, California, United States

View all 102 locations

View Trial Details

Completed

Continued Efficacy and Safety of Apomorphine in Patients With Late-Stage Parkinsons Disease

NCT00200525

Conditions: Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +6 more
Locations: Not specified

View Trial Details

Completed

Continued Efficacy of Apomorphine After Previous Exposure of at Least Three Months

NCT00200512

Conditions: Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +6 more
Locations: Walton Centre for Neurology and Neurosurgery Liverpool, United Kingdom

The Morriston Hospital Swansea, United Kingdom

View Trial Details

Completed

Randomized Study of the Effects of Glucose on Cognition in Healthy Young and Elderly People and Parkinson's Disease Patients

NCT00004451

Conditions: Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +13 more
Locations: University of Virginia Charlottesville, Virginia, United States

View Trial Details

Completed

A Sub-Study With Patients in APO401 to Evaluate Adverse Events During Dose Introduction in Apomorphine-naïve Patients.

NCT00145171

Conditions: Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +6 more
Locations: Not specified

View Trial Details

Completed

Long Term Safety and Efficacy of SC Apomorphine in Treatment of "Off" Episodes in Late-Stage Parkinson's Disease

NCT00142545

Conditions: Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +6 more
Locations: Mylan Pharmaceuticals Morgantown, West Virginia, United States

View Trial Details

Completed

Continuously Infused Intracerebral (IC) Recombinant-Methionyl Human Glial Cell Line-Derived Neurotrophic Factor (r-metHuGDNF) for the Treatment of Idiopathic Parkinson's Disease

NCT00006488

Conditions: Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +6 more
Locations: Department of Neurology New York, United States

View Trial Details

Completed

Phase II Double Blind Controlled Trial of Nigral Grafting in Patients With Parkinson's Disease

NCT00004387

Conditions: Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +13 more
Locations: Not specified

View Trial Details

Completed

Phase II Study of Pallidotomy for Parkinson Disease

NCT00004670

Conditions: Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +13 more
Locations: Not specified

View Trial Details